Abstract:
PROBLEM TO BE SOLVED: To obtain new compounds effective for treating diseases mediated by cyclooxygenase 2, to provide a method for producing the same and to obtain pharmaceutical compositions comprising the compounds. SOLUTION: The new compounds are represented by formulas (1), (2) and (3) The methods for producing the compounds are provided. The pharmaceutical compositions comprise the compounds.
Abstract:
PROBLEM TO BE SOLVED: To obtain a new compound useful in pharmaceutical compositions for treating inflammatory diseases sensitive to the therapies using nonsteroidal anti-inflammatory agents. SOLUTION: This new compound is shown by formula I [X-Y-Z is such as to be CH2CH2CH2, C(O)CH2CH2, S-N=CH, or the like when side (b) is a double bond and side (a) and side (c) are each a single bond, =N-S-CH=, =N-O-CH=, =N-S-N=, or the like when side (a) and side (c) are each a double bond and side (b) is a single bond; R1 is S(O)2CH3, S(O)2NHC(O)CF3, P(O)(CH3)OH, or the like; R2 is a 1-6C alkyl, 3-7C cycloalkyl, trisubstituted phenyl or the like], e.g. 3-[4-(aminosulfonyl)phenyl]-2-(4-fluorophenyl)-5-(2- hydroxy-2-propyl)thiophene. The compound of formula I is obtained, for example, by using a ketone of formula II (Ra is SMe or the like) as starting material to form a compound of formula III (R4 is H or the like).
Abstract:
Compounds having formula (I) are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating diarrhea, hypertension, angina, platelet aggregation, cerebral spasm, premature labor, spontaneous abortion, dysmenorrhea, and migraine.
Abstract:
The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).
Abstract:
Compounds having the formula: are selective antagonists of leukotrienes of D4. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents and may be made up into pharmaceutical compositions. In the formula R is H, halogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, -CF3, -OR , -SR , -NR R , -CHO, -COOR , -(C=0)R , -C(OH)R R , -CN, -NO2, substituted or unsubstituted phenyl, substituted or unsubstituted benzyl, or substituted or unsubstituted phenethyl; R is H, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, -CF3, substituted or unsubstituted phenyl, substituted or unsubstituted benzyl, or substituted or unsubstituted phenethyl; R is -(A)m-(CR =CR )p-(CR R )m-Q; R is H, halogen, -NO2, -CN, -OR , -SR , NR R , or C1-C8 alkyl; R is H or C1-C4 alkyl; R is A) a monocyclic or bicyclic heterocyclic radical containing from 3 to 12 nuclear carbon atoms and 1 or 2 nuclear heteroatoms selected from N and S with at least one being N, and with each ring in the heterocyclic radical being formed of 5 or 6 atoms, or B) the radical W-R ; R contains up to 21 carbon atoms and is (1) a hydrocarbon radical or (2) an acyl radical of an organic acyclic or monocyclic carboxylic acid containing not more than 1 heteroatom in the ring; R is -OR , -SR , or NR R ; R is H, C1-C6 alkyl, -(C=O)R , unsubstituted phenyl or unsubstituted benzyl; R is H, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, -CF3, or unsubstituted phenyl, benzyl, or phenethyl; m is 0-8; n is 1 or 2;
Abstract translation:具有下式的化合物:是D4的白三烯的选择性拮抗剂。 这些化合物可用作抗哮喘,抗过敏,抗炎和细胞保护剂,并且可以制成药物组合物。 在式中,R 1是H,卤素,C 1 -C 8烷基,C 2 -C 8烯基,C 2 -C 8炔基,-CF 3,-OR 2,-SR 2,-NR 2 R 2 >,-CHO,-COOR 2, - (C = O)R 2,-C(OH)R 2 R 2,-CN,-NO 2,取代或未取代的苯基,取代或未取代的 苄基或取代或未取代的苯乙基; R 2是H,C 1 -C 8烷基,C 2 -C 8烯基,C 2 -C 8炔基,-CF 3,取代或未取代的苯基,取代或未取代的苄基或取代或未取代的苯乙基; R 3是 - (A)m - (CR 2 = CR 2)p - (CR 2 R 2)m -Q; R 4是H,卤素,-NO 2,-CN,-OR 2,-SR 2,NR 2 R 2或C 1 -C 8烷基; R 6是H或C 1 -C 4烷基; R 7是A)含有3至12个核碳原子和1或2个选自N和S的核杂原子,至少一个为N的单环或双环杂环基,杂环基中的每个环由 5或6个原子,或B)基团WR 8; R 8含有最多21个碳原子,并且(1)烃基或(2)环中含有不超过1个杂原子的有机无环或单环羧酸的酰基; R 9是-OR 1,O,R 1,R 2,R 11, R 1是H,C 1 -C 6烷基, - (C = O)R 1,未取代的苯基或未取代的苄基; R 1是H,C 1 -C 8烷基,C 2 -C 8烯基,C 2 -C 8炔基,-CF 3或未取代的苯基,苄基或苯乙基; m为0-8; n为1或2;
Abstract:
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
Abstract:
The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).
Abstract:
Cette invention concerne une nouvelle classe de composés qui sont des inhibiteurs de cystéines protéases, y compris mais sans y être limités, des inhibiteurs des cathepsines K, L, S et B. Ces composés sont utiles pour traiter des maladies dans lesquelles l'inhibition de la résorption osseuse est indiquée, telles que l'ostéoporose.
Abstract:
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.